Gene: Poteh (POTE ankyrin domain family member H) Rattus norvegicus |
|
Analyze |
|
Symbol: |
Poteh |
Name: |
POTE ankyrin domain family member H |
RGD ID: |
2323175 |
Description: |
Orthologous to human POTEH (POTE ankyrin domain family member H); INTERACTS WITH bisphenol A; aflatoxin B1 (ortholog); amiodarone (ortholog). |
Type: |
protein-coding
|
RefSeq Status: |
MODEL |
Previously known as: |
ankyrin repeat domain-containing protein 26-like; coiled-coil domain-containing protein 144A-like; LOC100363368; mCG11429-like |
RGD Orthologs |
|
Alliance Orthologs |
|
More Info |
more info ...
|
More Info |
|
Latest Assembly: |
mRatBN7.2 - mRatBN7.2 Assembly |
Position: |
Rat Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
GRCr8 | 15 | 19,559,450 - 19,654,345 (+) | NCBI | | GRCr8 | | | mRatBN7.2 | 15 | 17,131,582 - 17,219,924 (+) | NCBI | mRatBN7.2 | mRatBN7.2 | | | Rnor_6.0 | 15 | 18,919,299 - 19,008,178 (+) | NCBI | Rnor6.0 | Rnor_6.0 | rn6 | Rnor6.0 | Rnor_5.0 | 15 | 22,885,738 - 22,973,003 (+) | NCBI | Rnor5.0 | Rnor_5.0 | rn5 | Rnor5.0 | RGSC_v3.4 | 15 | 19,121,888 - 19,160,715 (+) | NCBI | RGSC3.4 | RGSC_v3.4 | rn4 | RGSC3.4 | Celera | 15 | 17,086,946 - 17,173,612 (+) | NCBI | | Celera | | | Cytogenetic Map | 15 | p14 | NCBI | | | | |
|
JBrowse: |
View Region in Genome Browser (JBrowse)
|
Model |
|
|
References
Genomics
Comparative Map Data
Poteh (Rattus norvegicus - Norway rat) |
Rat Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
GRCr8 | 15 | 19,559,450 - 19,654,345 (+) | NCBI | | GRCr8 | | | mRatBN7.2 | 15 | 17,131,582 - 17,219,924 (+) | NCBI | mRatBN7.2 | mRatBN7.2 | | | Rnor_6.0 | 15 | 18,919,299 - 19,008,178 (+) | NCBI | Rnor6.0 | Rnor_6.0 | rn6 | Rnor6.0 | Rnor_5.0 | 15 | 22,885,738 - 22,973,003 (+) | NCBI | Rnor5.0 | Rnor_5.0 | rn5 | Rnor5.0 | RGSC_v3.4 | 15 | 19,121,888 - 19,160,715 (+) | NCBI | RGSC3.4 | RGSC_v3.4 | rn4 | RGSC3.4 | Celera | 15 | 17,086,946 - 17,173,612 (+) | NCBI | | Celera | | | Cytogenetic Map | 15 | p14 | NCBI | | | | |
|
POTEH (Homo sapiens - human) |
Human Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
GRCh38 | 22 | 15,690,026 - 15,721,631 (+) | NCBI | GRCh38 | GRCh38 | hg38 | GRCh38 | GRCh38.p14 Ensembl | 22 | 15,690,026 - 15,721,631 (+) | Ensembl | GRCh38 | | hg38 | GRCh38 | GRCh37 | 22 | 16,256,332 - 16,287,937 (-) | NCBI | GRCh37 | GRCh37 | hg19 | GRCh37 | Build 36 | 22 | 14,636,332 - 14,667,937 (-) | NCBI | NCBI36 | Build 36 | hg18 | NCBI36 | Build 34 | 14 | 19,058,805 - 19,090,272 | NCBI | | | | | Cytogenetic Map | 22 | q11.1 | NCBI | | | | | HuRef | 22 | 72,736 - 82,738 (-) | NCBI | | HuRef | | | CHM1_1 | 22 | 16,257,042 - 16,288,874 (-) | NCBI | | CHM1_1 | | | T2T-CHM13v2.0 | 22 | 16,263,953 - 16,295,528 (+) | NCBI | | T2T-CHM13v2.0 | | |
|
Potegl (Mus musculus - house mouse) |
Mouse Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
GRCm39 | 2 | 23,094,769 - 23,157,141 (+) | NCBI | GRCm39 | GRCm39 | mm39 | | GRCm39 Ensembl | 2 | 23,097,488 - 23,157,141 (+) | Ensembl | | GRCm39 Ensembl | | | GRCm38 | 2 | 23,204,748 - 23,267,129 (+) | NCBI | GRCm38 | GRCm38 | mm10 | GRCm38 | GRCm38.p6 Ensembl | 2 | 23,207,476 - 23,267,129 (+) | Ensembl | GRCm38 | | mm10 | GRCm38 | MGSCv37 | 2 | 23,062,996 - 23,122,649 (+) | NCBI | GRCm37 | MGSCv37 | mm9 | NCBIm37 | MGSCv36 | 2 | 23,029,485 - 23,089,127 (+) | NCBI | | MGSCv36 | mm8 | | Celera | 2 | 22,939,280 - 22,999,116 (+) | NCBI | | Celera | | | Cytogenetic Map | 2 | A3 | NCBI | | | | | cM Map | 2 | 15.25 | NCBI | | | | |
|
QTLs in Region (mRatBN7.2)
1354657 | Despr13 | Despair related QTL 13 | | 0.0022 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 15 | 1 | 29912054 | Rat | 8552920 | Pigfal8 | Plasma insulin-like growth factor 1 level QTL 8 | 3 | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 15 | 1 | 34723002 | Rat | 8694361 | Abfw6 | Abdominal fat weight QTL 6 | 10.2 | 0.001 | visceral adipose mass (VT:0010063) | abdominal fat pad weight to body weight ratio (CMO:0000095) | 15 | 1 | 34723002 | Rat | 9589149 | Insul29 | Insulin level QTL 29 | 9.06 | 0.001 | blood insulin amount (VT:0001560) | plasma insulin level (CMO:0000342) | 15 | 1 | 34723002 | Rat | 731170 | Pur3 | Proteinuria QTL 3 | 2.3 | 0.0005 | urine protein amount (VT:0005160) | urine protein excretion rate (CMO:0000759) | 15 | 1 | 41686771 | Rat | 1641887 | Alcrsp14 | Alcohol response QTL 14 | | | response to alcohol trait (VT:0010489) | brain neurotensin receptor 1 density (CMO:0002068) | 15 | 1 | 42356671 | Rat | 2298549 | Neuinf12 | Neuroinflammation QTL 12 | 3.5 | | nervous system integrity trait (VT:0010566) | spinal cord beta-2 microglobulin mRNA level (CMO:0002125) | 15 | 1 | 55302115 | Rat | 10401805 | Kidm51 | Kidney mass QTL 51 | | | kidney mass (VT:0002707) | both kidneys wet weight (CMO:0000085) | 15 | 306329 | 45306329 | Rat | 1641913 | Colcr2 | Colorectal carcinoma resistance QTL 2 | 6.57 | 0.0197 | intestine integrity trait (VT:0010554) | colorectal tumor number (CMO:0001794) | 15 | 2266368 | 22711984 | Rat | 1641913 | Colcr2 | Colorectal carcinoma resistance QTL 2 | 6.57 | 0.0197 | intestine integrity trait (VT:0010554) | poorly differentiated malignant colorectal tumor number (CMO:0002076) | 15 | 2266368 | 22711984 | Rat | 738017 | Hcas7 | Hepatocarcinoma susceptibility QTL 7 | 2.91 | | liver integrity trait (VT:0010547) | liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464) | 15 | 2266368 | 46921453 | Rat | 1582251 | Gluco24 | Glucose level QTL 24 | 3.2 | 0.0008 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 15 | 5530756 | 50530756 | Rat | 631273 | Lecl2 | Lens clarity QTL 2 | | 0.001 | lens clarity trait (VT:0001304) | age of onset/diagnosis of cataract (CMO:0001584) | 15 | 10596089 | 55596089 | Rat | 2300167 | Bmd63 | Bone mineral density QTL 63 | 5.9 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 15 | 11111142 | 56111142 | Rat | 2300173 | Bmd62 | Bone mineral density QTL 62 | 12.8 | 0.0001 | lumbar vertebra mineral mass (VT:0010511) | volumetric bone mineral density (CMO:0001553) | 15 | 11111142 | 56111142 | Rat | 2293688 | Bss29 | Bone structure and strength QTL 29 | 5.31 | 0.0001 | femur morphology trait (VT:0000559) | femur midshaft cortical cross-sectional area (CMO:0001663) | 15 | 11111142 | 56111142 | Rat | 2317750 | Glom26 | Glomerulus QTL 26 | 4.3 | | urine protein amount (VT:0005160) | urine protein level (CMO:0000591) | 15 | 12496141 | 65205939 | Rat | 5685002 | Bss103 | Bone structure and strength QTL 103 | 2.8 | | tibia strength trait (VT:1000284) | tibia total energy absorbed before break (CMO:0001736) | 15 | 14481165 | 28469888 | Rat | 61424 | Scl1 | Serum cholesterol level QTL 1 | 7.7 | 0.001 | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 15 | 16725528 | 80672115 | Rat | |